الولايات المتحدة · مجلات اقتصادية · Quartz

3 next-generation weight-loss drugs at different stages of FDA review and trials

نشره Quartz · الولايات المتحدة منذ 2 س

The next weight-loss drugs to watch are CagriSema, retatrutide and aleniglipron, three obesity candidates at different stages of testing and FDA review, and only one has been filed

اقرأ المقال كاملًا على Quartz سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (qz.com)

يستحق القراءة أيضًا

Inc.

The Johns Hopkins Breach Wasn’t Caused by a Hacker. It Started With 1 Employee Upload

Kiplinger

The AI Boom Has a Warning System. Here's What It's Saying Now

Fox Business

Nelson Peltz-led group offers to buy Wendy’s for $1.4B

Fast Company

Daylight saving time is spooky this year: What to know about the 2026 clock change

Entrepreneur

McDonald’s Says There’s Such a Thing as a Bad Big Mac. Now It’s Training 2 Million Workers to Taste the Difference.

Markets Insider (Business Insider)